Weigang Meng

Weigang’s recent representative experience includes advising:

• The joint sponsors and underwriters on the HK$1.4 billion initial public offering of Drinda, a leading specialized manufacturer of photovoltaic cells, on The Stock Exchange of Hong Kong
• J&T Express, a global logistics service provider, on its HK$3.5 billion initial public offering on the Hong Kong Stock Exchange; this multi-award winning deal was named Equity Market Deal of the Year – Midsize at the ALB China Law Awards 2024, Best IPO: China-Offshore at the FinanceAsia Achievement Awards 2024, Equity Market Deal of the Year at the ALB SE Asia Law Awards 2024, Equity Deal of the Year at the IFLR Asia-Pacific Awards 2024, and one of the Equity Capital Markets Deals of the Year by China Business Law Journal 2023
• Yonghe Medical Group Co., Ltd. in its US$192 million IPO and listing on the Hong Kong Stock Exchange*
• Acotec Scientific Holdings Limited in its US$210 million IPO and listing on the Hong Kong Stock Exchange*
• China Zheshang Bank Co., Ltd. in its US$1.75 billion H-share listing*
• China Huarong Asset Management Co., Ltd. in its US$2.3 billion H-share listing*
• The underwriters in the US$154 million spin-off and listing of Greentown Management Holdings Company Limited in Hong Kong*
• Qingdao Port International Co., Ltd. in its US$840 million H-share placement*
• The underwriters in the US$150 million H-share listing of Inner Mongolia Energy Engineering Co., Ltd.*
• The underwriters in the US$114 million H-share listing of Guangdong Kanghua Healthcare Co., Ltd.*
• Beijing Jingneng Clean Energy Co., Ltd. in its US$162 million H-share placement*
• The underwriters in the US$1.96 billion H-share listing of China Energy Engineering Corporation Limited*
• The underwriters in the US$4.2 billion H-share listing of Dalian Wanda Commercial Properties Co., Ltd.* 

*Matter handled prior to joining Latham